Molecular Biomarkers in Renal Transplantation Via TruGraf® Test

Clinical Trial ID NCT04398498

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04398498

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 9.02
2 Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2010 4.09
3 Survival benefit of solid-organ transplant in the United States. JAMA Surg 2015 2.34
4 OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant 2015 2.11
5 One kidney for life. Am J Transplant 2014 2.00
6 Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998 1.54
7 Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006 1.50
8 Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994 1.19
9 Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int 2007 1.17
10 The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006 1.17
11 Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant 2010 1.07
12 2202 kidney transplant recipients with 10 years of graft function: what happens next? Am J Transplant 2008 1.02
13 Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998 0.94
14 Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. Transplantation 1999 0.93
15 Drug minimization in transplantation: an opinion. Curr Opin Organ Transplant 2014 0.77
Next 100